Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Change in Acquisitions & Divestments: 2020-2025

Historic Change in Acquisitions & Divestments for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Sep 2025 value amounting to $18.8 million.

  • Mirum Pharmaceuticals' Change in Acquisitions & Divestments rose 142.84% to $18.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.5 million, marking a year-over-year decrease of 23.68%. This contributed to the annual value of $19.9 million for FY2024, which is 87.00% down from last year.
  • Latest data reveals that Mirum Pharmaceuticals reported Change in Acquisitions & Divestments of $18.8 million as of Q3 2025, which was down 24.91% from $25.1 million recorded in Q2 2025.
  • In the past 5 years, Mirum Pharmaceuticals' Change in Acquisitions & Divestments ranged from a high of $64.5 million in Q1 2023 and a low of $3.0 million during Q4 2023.
  • Its 3-year average for Change in Acquisitions & Divestments is $26.0 million, with a median of $18.8 million in 2025.
  • Per our database at Business Quant, Mirum Pharmaceuticals' Change in Acquisitions & Divestments skyrocketed by 400.00% in 2021 and then plummeted by 88.89% in 2023.
  • Mirum Pharmaceuticals' Change in Acquisitions & Divestments (Quarterly) stood at $38.0 million in 2021, then dropped by 28.95% to $27.0 million in 2022, then crashed by 88.89% to $3.0 million in 2023, then surged by 304.80% to $12.1 million in 2024, then spiked by 142.84% to $18.8 million in 2025.
  • Its Change in Acquisitions & Divestments was $18.8 million in Q3 2025, compared to $25.1 million in Q2 2025 and $17.4 million in Q1 2025.